Ernexa Therapeutics Inc. (ERNA) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-07-02 | 8-K | Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2026-07-02 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-06-26 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2026-05-04 | 8-K | Charter Amendments, Financial Statements & Exhibits | SEC |
| 2026-03-20 | 8-K | Listing Notice | SEC |
| 2026-02-26 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-02-11 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2025-12-11 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-07-07 | 8-K | Auditor Change, Financial Statements & Exhibits | SEC |
| 2025-06-12 | 8-K | Charter Amendments, Financial Statements & Exhibits | SEC |
| 2025-06-09 | 8-K | Unregistered Sales, Other Events | SEC |
| 2025-06-02 | 8-K | Charter Amendments, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2025-04-03 | 8-K | Material Agreement, Unregistered Sales, Item 5.08, Financial Statements & Exhibits | SEC |
| 2025-03-26 | 8-K | Charter Amendments, Financial Statements & Exhibits | SEC |
| 2025-03-24 | 8-K | Material Agreement, Direct Financial Obligation, Financial Statements & Exhibits | SEC |
| 2025-03-12 | 8-K | Material Agreement, Direct Financial Obligation, Financial Statements & Exhibits | SEC |
| 2025-02-13 | 8-K | Item 5.08 | SEC |
| 2025-01-10 | 8-K | Listing Notice, Officer / Director Changes | SEC |
| 2025-01-03 | 8-K | Listing Notice | SEC |
| 2024-10-29 | 8-K | Material Agreement, Unregistered Sales, Shareholder Vote Results, Other Events, Financial Statements & Exhibits | SEC |
| 2024-09-27 | 8-K | Material Agreement, Termination of Agreement, Financial Statements & Exhibits | SEC |
| 2024-09-25 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Other Events, Financial Statements & Exhibits | SEC |
| 2024-09-23 | 8-K | Listing Notice | SEC |
| 2024-08-19 | 8-K | Other Events | SEC |
| 2024-03-22 | 8-K | Listing Notice | SEC |
| 2024-02-16 | 8-K | Officer / Director Changes | SEC |
| 2024-01-19 | 8-K | Listing Notice | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.